We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Screening for Abdominal Aortic Aneurysm in 65 Year Old Males in Oslo (AAAscreening)

This study is enrolling participants by invitation only.
ClinicalTrials.gov Identifier:
First Posted: November 25, 2010
Last Update Posted: March 30, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Jorgen J Jorgensen, Oslo University Hospital
Male subjects, 65 years of age, living in Oslo, Norway will be invited to be screened for abdominal aortic aneurysm.

Abdominal Aortic Aneurysm

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Screening for Abdominal Aortic Aneurysm

Resource links provided by NLM:

Further study details as provided by Jorgen J Jorgensen, Oslo University Hospital:

Primary Outcome Measures:
  • Abdominal Aortic Aneurysm (AAA) [ Time Frame: Yearly the number of patients with AAA among the screened population will be assessed during the inclusion period of 18 years.. ]
    AAA definition: diameter equal or more than 30 mm. The number of identified patients with AAA will be yearlig assessed.

Secondary Outcome Measures:
  • Peripheral Arterial Disease (PAD) [ Time Frame: Yearly the number of patients with PAD among the screened poplulation will be assessed during the inclusion period of 18 years. ]
    Investigate the prevalence of PAD among patients with AAA defined as having Ankle-Arm Index (AAI) less than 0.9. The number of these patients will be assessed yearly.

Enrollment: 7500
Study Start Date: May 2011
Estimated Study Completion Date: December 2029
Estimated Primary Completion Date: December 2029 (Final data collection date for primary outcome measure)
Detailed Description:
The invited population will be offered ultrasound investigation of their abdominal aorta. Further information regarding risk factors will be noted and measurement of ankle-brachial index will be measured/calculated. A further step in the future will be to sample blood with focus on different cytokines and genmediators.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   65 Years to 65 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
65 year old males in Oslo

Inclusion Criteria:

  • Males aged 65 years

Exclusion Criteria:

  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Jorgen J Jorgensen, Professor dr.med., Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01248533     History of Changes
Other Study ID Numbers: 2009/866
First Submitted: November 11, 2010
First Posted: November 25, 2010
Last Update Posted: March 30, 2016
Last Verified: March 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: All data are entered into the Electronic Patient Journal of Oslo University Hospital (DIPS)

Keywords provided by Jorgen J Jorgensen, Oslo University Hospital:
Abdominal aortic aneurysm, atherosclerosis

Additional relevant MeSH terms:
Aortic Aneurysm
Aortic Aneurysm, Abdominal
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases